TY - JOUR
AU - A. Sud
AU - K. Chiu
AU - J. Friedman
AU - J. Dupouy
A1 - 
AD - Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Canada; Humber River Hospital, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada. Electronic address: abhimanyu.sud@utoronto.ca.; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Canada.; Center for Social Medicine and Humanities, University of California, Los Angeles, United States.; University Department of General Medicine, University of Toulouse, Faculty of Medicine, Toulouse, France; Inserm UMR1295, University of Toulouse III, Faculty of Medicine, Toulouse, France.
AN - 37619440
BT - Int J Drug Policy
C5 - Opioids & Substance Use; Healthcare Policy
DA - Oct
DO - 10.1016/j.drugpo.2023.104161
DP - NLM
ET - 20230822
JF - Int J Drug Policy
LA - eng
PY - 2023
SN - 0955-3959
SP - 104161
ST - Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States
T1 - Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States
T2 - Int J Drug Policy
TI - Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States
U1 - Opioids & Substance Use; Healthcare Policy
U3 - 10.1016/j.drugpo.2023.104161
VL - 120
VO - 0955-3959
Y1 - 2023
ER -